52
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Infection of Blood and Bone Marrow Cells with the Human Cytomegalovirus in Vivo

, &
Pages 445-454 | Published online: 01 Jul 2009

References

  • Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cemy R., Horsnell T., Kouzarides T., Martignetti J. A., et al. Analysis of the protein‐coding content of the sequence of human cytomegalovirus strain AD169. [Review]. Current Topics in Microbiology & Immunology 1990; 154: 125–169
  • Landini M. P., Seven B., Furlini G., Badiali De Giorgi L. Human cytomegalovirus structural components: intracellular and intraviral localization of p28 and p65–69 by immunoelectron microscopy. Virus Res. 1987; 8: 15–23
  • Keay S., Baldwin B. Anti‐idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment. J. Virol. 1991; 65: 5124–5128
  • Keay S., Merigan T. C., Rasmussen L. Identification of cell surface receptors for the 86‐kilodalton glycoprotein of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 1989; 86: 10100–10103
  • Adlish J. D., Lahijani R. S., St Jeor S. C. Identification of a putative cell receptor for human cytomegalovirus. Virology 1990; 176: 337–345
  • Gibson W., Irmiere A. Selection of particles and proteins for use as human cytomegalovirus subunit vaccines. [Review]. Birth Defects: Original Article Series 1984; 20, Original Ar‐Original 24
  • Irmiere A., Gibson W. Isolation and characterization of a noninfectious virion‐like particle released from cells infected with human strains of cytomegalovirus. Virology 1983; 130: 118–133
  • Suwansirikul S., Rao N., Dowling J. N., Ho M. Primary and secondary cytomegalovirus infection. Archives of Internal Medicine 1977; 137: 1026–1029
  • Verdonck L. F., de Gast G. C., van Heugten H. G., Nieuwenhuis H. K., Dekker A. W. Cytomegalovirus infection causes delayed platelet recovery after bone marrow transplantation. Blood 1991; 78: 844–848
  • Wingard J. R., Chen D. Y., Burns W. H., Fuller D. J., Braine H. G., Yeager A. M., Kaiser H., Burke P. J., Graham M. L., Santos G. W., et al. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation. Blood 1988; 71: 1432–1437
  • Peterson P. K., Balfour H. H., Jr., Marker S. C., Fryd D. S., Howard R. J., Simmons R. L. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 1980; 59: 283–300
  • Ljungman P., Niederwieser D., Pepe M. S., Longton G., Storb R., Meyers J. D. Cytomegalovirus infection after marrow transplantation for aplastic anemia. Bone Marrow Transplant 1990; 6: 295–300
  • Rubie H., Attal M., Campardou A. M., Gayel Mengelle C., Payen C., Sanguignol F., Calol J. P., Charlet J. P., Rubert A., Huguet F., et al. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products. Bone Marrow Transplant 1993; 11: 209–214
  • Goodrich J. M., Bowden R. A., Fisher L., Keller C., Schoch G., Meyers J. D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med. 1993; 118: 173–178, 30
  • Schmidt G. M., Horak D. A., Niland J. C., Duncan S. R., Forman S. J., Zaia J. A. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants: The City of Hope‐Stanford‐Syntex CMV Study Group [see comments]. N. Engl. J. Med. 1991; 324: 1005–1011
  • Winston D. J., Ho W. G., Bartoni K., Du Mond C., Ebeling D. F., Buhles W. C. C. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo‐controlled, double‐blind trial. Ann. Intern. Med. 1993; 118: 179–184
  • Grattan M. T., Moreno‐Cabral C. E., Starnes V. A., Oyer P. E., Stinson E. B. S. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561–3566
  • Gross J. G., Bozzette S. A., Mathews W. C., Spector S. A., Abramson I. S., McCutchan J. A., Mendez T., Munguia D., Freeman W. R. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990; 97: 681–686
  • Vinters H. V., Kwok M. K., Ho H. W., Anders K. H., Tomiyasu U., Wolfson W. L. R. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989; 112: 245–268
  • Chatterjee S. N., Fiala M., Weiner J., Stewart J. A., Stacey B., Warmer N. Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA 1978; 240: 2446–2449
  • Hofflin J. M., Potasman I., Baldwin J. C., Oyer P. E., Stinson E. B., Remington J. S. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann. Intern. Med. 1987; 106: 209–216
  • Taylor Wiedeman J., Sissons J. G., Borysiewicz L. K., Sinclair J. H. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 1991; 72: 2059–2064
  • Taylor Wiedeman J., Hayhurst G. P., Sissons J. G., Sinclair J. H. Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J. Gen. Virol. 1993; 74: 265–268
  • Lang D. J., Ebert P. A., Rodgers B. M., Boggess H. P., Rixse R. S. Reduction of postperfusion cytomegalovirus‐infections following the use of leukocyte depleted blood. Transfusion 1977; 17: 391–395
  • Gerna G., Revello M. G., Percivalle E., Zavaltoni M., Parea M., Battaglia M. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J. Clin. Microbiol. 1990; 28: 2681–2688
  • Nelson J. A., Gnann J. W. J., Ghazal P. Regulation and tissue‐specific expression of human cytomegalovirus. Curr. Top. Microbiol. Immunol. 1990; 154: 75–100
  • Revello M. G., Percivalle E., Di Matteo A., Morini F., Gerna G. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viracmic patients. J. Gen. Virol. 1992; 73: 437–142
  • Rice G. P., Schrier R. D., Oldstone M. B. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate‐early gene products. Proc. Natl. Acad. Sci. USA 1984; 81: 6134–6138
  • Einhorn Lena, Öst Ake. Cytomegalovirus infection of human blood cells. J. Infect. Dis. 1984; 149: 207–214
  • Braun R. W., Reiser H. C. Replication of human cytomegalovirus in human peripheral blood T cells. J. Virol. 1986; 60: 29–36
  • Ibanez C. E., Schrier R., Ghazal P., Wiley C., Nelson J. A. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 1991; 65: 6581–6588
  • Lathey J. L., Spector S. A. Unrestricted replication of human cytomegalovirus in hydrocortisone‐treated macrophages. J. Virol. 1991; 65: 6371–6375
  • Maciejewski J. P., Bruening E. E., Donahue R. E., Sellers S. E., Carter C., Young N. S., St Jeor S. Infection of mononucleated phagocytes with human cytomegalovirus. Virology 1993; 195: 327–336
  • Grefte J. M., van der Gun B. T., Schmolke S., van der Giessen M., van Son W. J. P., Jahn G., The T. H. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J. Gen. Virol. 1992; 73: 2923–2932
  • Gerna G., Revello M. G., Percivalle E., Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphopro‐tein (pp65) for optimal quanlitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 1992; 30: 1232–1237
  • Gerna G., Zipeto D., Percivalle E., Parea M., Revello M. G., Maccario R. P., Milanesi G. Human cytomegalovirus infection of the major leukocyte subpopula‐tions and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J. Infect. Dis. 1992; 166: 1236–1244
  • Dankner W. M., McCutchan J. A., Richman D. D., Hirata K., Spector S. A. Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization. J. Infect. Dis. 1990; 161: 31–36
  • Turtinen L. W., Saltzman R., Jordan M. C., Haase A. T. Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microb. Pathog. 1987; 3: 287–297
  • Martin D. C., Katzenstein D. A., Yu G. S. M., Jordan M. C. Cytomegalovirus viremia detected by molecular hybridisation and electron microscopy. Ann. Intern. Med. 1984; 100: 222–225
  • Saltzman R. L., Quirk M. R., Jordan M. C. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest 1988; 81: 75–81
  • Rinaldo C. R., Black P. H., Hirsch M. S. Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J. Infect. Dis. 1977; 136: 667–676
  • Meyer‐König U., Serr A., von Laer D., Kirste G., Wolff C., Haller O., Neumman‐Haefelin D., Hufert F. T. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. J. Infect. Dis. 1995; 171: 607–613
  • von Laer D., Serr A., Meyer‐König U., Kirste G., Hufert F. T., Haller O. Cytomegalovirus immediate early and late transcripts in all major leucocyte populations in vivo. J. Infect. Dis. 1995; 172: 365–370
  • Buffone G. J., Hine E., Demmler G. J. Detection of mRNA from the immediate early gene of human cylomegalovirus in infected cells by in vitro amplification. Mol. Cell Probes 1990; 4: 143–151
  • Bitsch A., Kirchner H., Dupke R., Bein G. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription‐polymerase chain reaction. J. Infect. Dis. 1993; 167: 740–743
  • Rosenfeld S. J., Young N. S. Viruses and bone marrow failure. [Review]. Blood Reviews 1991; 5: 71–77
  • Apperley J. F., Dowding C., Hibbin J., Buiter J., Matutes E., Sissons P. J., Gordon M., Goldman J. M. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 1989; 17: 38–45
  • MacKintosh F. R., Adlish J., Hall S. W., St Jeor S., Smith E., Tavassoli M. Z., Zanjani E. D. Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp. Hematol. 1993; 21: 243–250
  • Simmons P., Kaushansky K., Torok‐Storb B. Mechanisms of cytomegalovirus‐mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 1990; 87: 1386–1390
  • Rakusan T. A., Juneja H. S., Fleischmann W. R. J. Inhibition of hemopoietic colony formation by human cytomegalovirus in vitro. J. Infect. Dis. 1989; 159: 127–130
  • Sing G. K., Ruscetti F. W. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood 1990; 75: 1965–1973
  • Maciejewski J. P., Bruening E. E., Donahue R. E., Mocarski E. S., Young N. S., St Jeor S. C. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992; 80: 170–178
  • Preiksaitis J. K., Janowska Wieczorek A. Persistence of cytomegalovirus in human long‐term bone marrow culture: relationship to hemopoiesis. J. Med. Virol. 1991; 35: 76–84
  • Minton E. J., Tysoe C., Sinclair J. H., Sissons J. G. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 1994; 68: 4017–4021
  • Chesney P. J., Taher A., Gilbert E. M. F., Shahidi N. T. Intranuclear inclusions in megakaryocytes in congenital cytomegalovirus infection. J. Pediatr. 1978; 92: 957–958
  • Golde D. W. Production, distribution, and fate of neutrophils. Hematology, W. J. Williams, E. Beutler, A. J. Erslev, M. A. Lichtman. McGraw‐Hill Publishing Company, N.Y. 1991; 4: 795
  • Griffiths P. D. Cytomegalovirus. Principles and practice of clinical virology, A. J. Zuckerman, J. E. Banatvala, J. R. Pattison. John Wiley & Sons, West Sussex 1990; 2: 69
  • von Laer D., Meyer‐Koenig U., Serr A., Finke J., Kanz L., Fauser A. A.N. H., Brugger W., Hufert F. T. Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow. Blood 1995; 86: 4086–4090

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.